1. Ronald A. Asherson—“In Memoriam”

   • Yehuda Shoenfeld
   • M. Eric Gershwin
   • Ricard Cervera

   OriginalPaper 17 December 2008 Pages: 71 - 73

2. Clinical and Laboratory Features of the Catastrophic Antiphospholipid Syndrome

   • Ljudmila Stojanovich
   • Dragomir Marisavljevic
   • Nikola Milinic

   OriginalPaper 04 December 2008 Pages: 74 - 79

3. Catastrophic Antiphospholipid Syndrome: Treatment, Prognosis, and the Risk of Relapse

   • Silvia Bucciarelli
   • Doruk Erkan
   • Ricard Cervera

   OriginalPaper 02 December 2008 Pages: 80 - 84

   

4. Pregnancy and Catastrophic Antiphospholipid Syndrome

   • Jose A. Gómez-Puerta
   • Jose Sanin-Blair
   • Claudio Galarza-Maldonado

   OriginalPaper 04 December 2008 Pages: 85 - 90

5. Malignancies and Catastrophic Anti-phospholipid Syndrome

   • Wolfgang Miesbach

   OriginalPaper 02 December 2008 Pages: 91 - 97

6. The Catastrophic Antiphospholipid Syndrome in Serbia: Diagnostic and Management Problems

   • Ljudmila Stojanovich

   OriginalPaper 02 December 2008 Pages: 98 - 103

7. Infections and the Antiphospholipid Syndrome

   • Mario García-Carrasco
   • Claudio Galarza-Maldonado
   • Ricard Cervera

   OriginalPaper 17 December 2008 Pages: 104 - 108

8. Microthrombotic/Microangiopathic Manifestations of the Antiphospholipid Syndrome

   • Sonja Praprotnik
   • Dušan Ferluga
   • Blaž Rozman

   OriginalPaper 09 December 2008 Pages: 109 - 125

   

9. Revisiting Libman–Sacks Endocarditis: A Historical Review and Update

   • Jennifer L. Lee
   • Stanley M. Naguwa
   • M. Eric Gershwin

   OriginalPaper 17 December 2008 Pages: 126 - 130

   

10. Renal Involvement in the Antiphospholipid Syndrome (APS)—APS Nephropathy

    • Maria G. Tektonidou

    OriginalPaper 02 December 2008 Pages: 131 - 140

    

11. The Role of Complement in the Antiphospholipid Syndrome-Associated Pathology

    • Ingrid Avalos
    • George C. Tsokos

    OriginalPaper 09 December 2008 Pages: 141 - 144

12. Plasma Homocysteine Levels, The Prevalence of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Macrovascular Disorders in Systemic Sclerosis: Risk Factors for Accelerated Macrovascular Damage?

    • Szilvia Szamosi
    • Zoltán Csiki
    • Gabriella Szűcs

    OriginalPaper 18 December 2008 Pages: 145 - 149

    

13. Vascular Disease in Scleroderma

    • Fredrick M. Wigley

    OriginalPaper 09 December 2008 Pages: 150 - 175

14. Recent Advances in the Treatment of Systemic Sclerosis

    • Vasiliki Kalliopi K. Bournia
    • Panayiotis G. Vlachoyiannopoulos
    • M. Eric Gershwin

    OriginalPaper 10 January 2009 Pages: 176 - 200